Lalitha V Iyer

Sri International

$940,260

Attributed

$2,135,253

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $773.9K · FY2009–23

$1M$750K$500K$250K$0

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$2,135,253 · 3

By mechanism

R01$1,433,992 · 1

R21$668,465 · 1

N01$32,796 · 1

Top collaborators

Most similar at Sri International

Same institution · by research overlap

Deborah Bunin$11,920,896
Lawrence R Toll$15,551,699
Debra Burnin$9,670,591
Nurulain T Zaveri$24,519,975
Lalitha Iver$411,035

Others in their field

Top investigators on “Clinical Research”

David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
Sonia M Thomas · Research Triangle Institute$700,865,642
Jeffrey P Krischer · University Of South Florida$611,867,176
Barton F Haynes · Duke University$538,862,577

Research focus

Clinical ResearchAddictionIn VitroMetabolismPharmaceutical PreparationsAntineoplasticsDietary ConstituentDietary SupplementsCuesAlternative MedicineConsumptionDesignBrainBrain CellCysteineAntiporterAcetylcysteineCell LineCocaineCocaine DependencesCocaine UseColorectal NeoplasmsBypassAntioxidants

Grant awards (5)

IN VITRO METABOLISM AND NON-CLINICAL ADME STUDIES IDIQ CONTRACT. POP 9/27/21-9/26/26. NTE $3.5 MILLION.$32,796

N01 · FY2023 · DA · contact PI

Targeting System Xc- for the Treatment of Addiction$660,133

R01 · FY2010 · DA

Targeting System Xc- for the Treatment of Addiction$773,859

R01 · FY2009 · DA

Interaction Between Irinotecan and Dietary Flavonoids$335,626

R21 · FY2004 · CA

Interaction Between Irinotecan and Dietary Flavonoids$332,839

R21 · FY2003 · CA